Complement and atherogenesis: Binding of CRP to degraded, nonoxidized LDL enhances complement activation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 10, 1999, Pages 2348-2354

  Bhakdi, Sucharit ^a,c   Torzewski, Michael ^b   Klouche, Mariam ^a   Hemmes, Monika ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Inst of Med Microbiol and Hygiene   (Germany)

Author keywords

Atherogenesis; Complement; Corrective protein; LDL

Indexed keywords

C REACTIVE PROTEIN; CALCIUM ION; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE C; PHOSPHORYLCHOLINE; SUCROSE;

ARTICLE; ATHEROGENESIS; BINDING KINETICS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REACTION ANALYSIS;

EID: 0032851173     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.10.2348     Document Type: Article

References (38)

1. Vlaicu R, Nicolescu F, Rus HG, Christea A. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 1985;57:163-167.
2. Nicolescu F, Hugo F, Rus HG, Vlaicu R, Bhakdi S. Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries. Clin Exp Immunol. 1987;69:477-483.
3. Rowe IF, Walker LN, Bowyer DE, Soutar AK, Smith LC, Pepys MB. Immunohistochemical studies of C-reactive protein and apolipoprotein B in inflammatory and arterial lesions. J Pathol. 1985;145:241-249.
4. Reynolds GD, Vance RP. C-reactive protein immunohistochemical localzation in normal and atherosclerotic human aortas. Arch Pathol Lab Med. 1987;111:265-269.
5. Seifert PS, Hugo F, Hansson GK, Bhakdi S. Prelesional complement activation in experimental atherosclerosis: Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. Lab Invest. 1989;60:747-754.
6. Seifert PS, Hugo F, Tranum-Jensen J, Zahringer U, Muhly M, Bhakdi S. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions. J Exp Med. 1990;172:547-557.
7. Alving CR, Richards RL, Guirguis AH. Cholesterol-dependent human complement actiation resulting in damage to liposomal model membranes. J Immunol. 177;188:342-347.
8. Chao FF, Amende LM, Blanchette Mackie EJ, Skarlatos SI, Gamble W, Resau JH, Mergner WT, Kruth HS. Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas. Am J Pathol. 1988;131:73-83.
9. Simionescu N, Mora R, Vasile E, Lupu F, Filip DA, Simionescu M. Prelesional modifications of the vessel wall in hyperlipidemic atherogenesis. Extracellular accumulation of modified and reassembled lipoproteins. Ann N Y Acad Sci. 1990;598:1-16.
10. Frank JS, Fogelman AM. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J Lipid Res. 1989;30:967-978.
11. Bhakdi S, Dorweiler B, Kirchmann R, Torzewski J, Weise E, Tranum-Jensen J, Walev I, Wieland E. On the pathogenesis of atherosclerosis: Enzymatic transformation of human low density lipoprotein to an atherogenic moiety. J Exp Med. 1995;182:1959-1971.
12. Klouche M, Gottschling S, Gerl V, Hell W, Husmann M, Dorweiler B, Meβner M, Bhakdi S. Atherogenic properties of enzymatically degraded low density lipoprotein: Selective induction of MCP-1 and cytotoxic effects on human macrophages. Arterioscler Thromb Vasc Biol. 1998;18: 1376-1385.
13. Torzewski M, Klouche M, Hock J, Meβner M, Dorweiler B, Torzewski J Gabbert HE, Bhakdi S. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol. 1998;18:369-378.
14. Schmiedt W, Kinscherf R, Deigner HP, Kamencic H, Nauen O, Kilo J, Oelert H, Metz J, Bhakdi S. Complement C6-deficiency protects against diet-induced atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 1998;18:1790-1795.
15. Bhakdi S. Complement and atherogenesis: The unknown connection. Ann Med 1998;30:503-507.
16. Torzewski J, Bowyer DE, Waltenberger J, Fitzsimmons C. Processes in atherogenesis: Complement activation. Atherosclerosis. 1997;132: 131-138.
17. Torzewski J, Torzewski M, Bowyer DE, Fröhlich M, Koenig W, Walternberger J, Fitzsimmons C, Hombach V. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998;18:1386-1392.
18. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol. 1990;65:168-172.
19. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A in severe unstable angina. N Engl J Med. 1994;331:417-424.
20. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462-466.
21. Lindgren FT, Adamson GL, Jenson LC, Wood PD. Lipid and lipoprotein measurements in a normal adult American population. Lipids. 1975;10: 750-756.
22. Bhakdi S, Roth M, Nürnberger W. A simple method for quantitative measurement of C3d in human plasma. J Immunol Methods. 1984;74: 79-86.
23. Rowe IF, Soutar AK, Trayner IM, Balth ML, de Beer FC, Walker L, Bowyer D, Herbert J, Feinstein A, Pepys MB. Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins. J Exp Med. 1984; 159:604-616.
24. Stary H. The histological classification of atherosclerotic lesions in human coronary arteries. In: Fuster V, Ross R, Topol E, eds. Atherosclerosis and Coronary Artery Disease. New York, NY: Lippincott-Raven: 1996:463.
25. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141-212.
26. Volonakis JE. Complement activation by C-reactive protein complexes. Ann N Y Acad Sci. 1982;389:235-238.
27. Wolbink GJ. CRP-mediated activation of complement in vivo. J Immunol. 1996;157:473-479.
28. Borén J, Olin K, Lee I, Chait A, Wight TN, Innerarity TL. Identification of the principal proteoglycan-binding site in LDL. J Clin Invest. 1998; 101:2658-2664.
29. Mahley RW, Weisgreber KM, Innerarity TC. Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors. Biochim Biophys Acta. 1979;575:81-91.
30. Neufeld EF, Sando GN, Garvin AJ, Rome LH. The transport of lysosomal enzymes. J Supramol Struct. 1977;6:95-101.
31. Sando GN, Henke VL. Recognition and receptor-mediated endocytosis of the lysosomal acid lipase secreted by cultured human fibroblasts. J Lipid Res. 1982;23:114-123.
32. Sakurada T, Orimo H, Okabe H, Noma A, Murakami M. Purification and properties of cholesterol ester hydrolase from human aortic intima and media. Biochim Biophys Acta. 1976;424:204-212.
33. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen J. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-985.
34. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 1997;176:292-295.
35. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet. 1997;350:430-436.
36. Quinn T. Does Chlamydia pneumoniae cause coronary heart disease? Curr Opin Infect Dis. 1998;11:301-307.
37. de Beer FC, Soutar AK, Baltz ML, Trayner M, Feinstein A, Pepys MB. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med. 1982;156:230-242.
38. de Beer FC, Shine B, Pepys MB. Radiometric ligand binding assay for C-reactive protein. Complexed C-reactive protein is not detectable in acute phase serum. Clin Exp Immunol. 1982;50:231-237.